SUPERNUS PHARMACEUTICALS, INC. ($SUPN)
Filing Information
| Accession Number | 0001899935-26-000003 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 20, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
7,966
Total Value
$0.00
P&L
+inf% (+$380,456.16)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Restricted Stock Unit | Derivative | Feb 18, 2026 | Grant/Award | 2,989 | $0.00 | $0.00 | 2,989 | Direct | โ | View Details | |
Director | Director Stock Option (Right to Buy) | Derivative | Feb 18, 2026 | Grant/Award | 4,977 | $0.00 | $0.00 | 4,977 | Direct | โ | View Details |